Novo Nordisk (NVO) has launched its blockbuster weight-loss drug Wegovy in India, shortly after rival Eli Lilly (NYSE:LLY) introduced its popular weight loss/diabetes therapy Mounjaro in the country ...

Wegovy will be available in India in five strengths. While the lower doses (0.25 mg, 0.5 mg, and 1 mg) will be priced at ...

Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...

A MUM has revealed how she lost 6st using weight loss jabs after hitting a size 18. Ellen Ogley, 42, weighed 16st 12lbs at ...

A mum lost 6st on Mounjaro and has revealed the one thing she's done to keep the weight off for eight months after coming off ...

Ellen Ogley, 42, weighed 16st 12lbs and was a size 18 at her heaviest - but after losing six stone on Mounjaro the mum says ...

Wegovy is the first drug in India approved for both weight management and risk reduction of major adverse cardiovascular events in individuals with established heart disease.

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

Currently, two criteria must be met to qualify for the prescription. Firstly, a BMI of 40 or over is required, however, if ...

Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle rising obesity rates while facing competition from rival drugs.

Susan had tried diets before without success, but says one audio programme has seen her lose a third of her weight in under ...